A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic,
generalized histiocytic proliferation with prominent hemophagocytosis
associated with a systemic viral infection. Epstein-Barr virus (EBV)
is one candidate fo;this association but serologic and molecular biolo
gic studies have been lacking in many cases. Although VAHS is generall
y a benign process, EBV-associated hemophagocytic syndrome (EBV-AHS) i
s often fatal and has a relatively high mortality rate. Therefore, EBV
-AHS must be distinguished from VAHS caused by other viruses. Recent e
vidence indicates that the pathophysiology in EBV-AHS appears to be me
diated by the unrestricted release of cytokines produced by the EBV-in
fected T cells. Clinical and laboratory findings, the differential dia
gnosis, virology studies, pathophysiology, and treatment in EBV-AHS ar
e reviewed.